Page 31 of 32 · 745 questions tagged clinical-trials.
Conditions: STEP 3 · vomiting · 2 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
This matters because it predicts what a related molecule should do. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if…
Setup, so nobody has to ask: STEP 1 · 2.4 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The clinician who ordered the panel was not concerned; I would still like to understand it. I want to know whether this is a real physical effect or an artefact of…
Concretely: ATTAIN-1 · vomiting. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
What I am working with: constipation · tirzepatide · SURMOUNT-4. I have read the primary source rather than the summary, which has left me with more questions. I…
Stated plainly: SURPASS-3 · vomiting. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including the…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. This is one of those things that everyone repeats and…
Numbers first: 10 mg · dulaglutide. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
What I am working with: semaglutide · STEP 3. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My…
I have three data points across nine months, which I hope is enough to see a trend. I can do the algebra. I am not confident about the conversion factors. If there is…
The case in front of me: tirzepatide · SURMOUNT-OSA. I would like the mechanism, because I want to be able to reason about the cases nobody has written about. I have…
Stated plainly: 2.4 mg · mazdutide. I am trying to build something sustainable rather than something thorough that I will abandon. I have already decided the broad…
Concretely: constipation · semaglutide · SUSTAIN-6. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Conditions: semaglutide · SELECT. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know how confident…
What I am working with: PIONEER-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Concretely: PIONEER-4 · oral semaglutide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Has…
Stated plainly: 2.4 mg · cagrilintide. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my tolerance…
The clinician who ordered the panel was not concerned; I would still like to understand it. This is one of those things that everyone repeats and nobody derives. This…
Setup, so nobody has to ask: SUSTAIN-6 · a GLP-1 receptor agonist. I have read the primary source rather than the summary, which has left me with more questions. I…
Conditions: 7 mg · oral semaglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan…
The label documentation for the agent in question is ambiguous on exactly this point. The figures are clear enough; the question is what they mean and what they do…
What I am working with: SURPASS-2 · tirzepatide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…